Treatment of verruca vulgaris with topical cidofovir in an immunocompromised patient: A case report and review of the literature

Transplant Infectious Disease

Volumn 7, Issue 3-4, 2005, Pages 158-161

  Cha, S ^a   Johnston, L ^a   Natkunam, Y ^a   Brown, Janice ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cidofovir; Immunocompromised patients; Topical therapy; Verruca vulgaris

Indexed keywords

ALENDRONIC ACID; AMSACRINE; ANTIVIRUS AGENT; ATENOLOL; AZACITIDINE; CIDOFOVIR; CITALOPRAM; CLINDAMYCIN; COTRIMOXAZOLE; DOXEPIN; ERYTHROMYCIN; ETOPOSIDE; GENTAMICIN; MULTIVITAMIN; PENICILLIN G; PREDNISONE; VANCOMYCIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ANAMNESIS; ANTIVIRAL ACTIVITY; BACTERIAL INFECTION; CASE REPORT; CELLULITIS; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL FEATURE; CREAM; CYTOMEGALOVIRUS; DNA VIRUS; DRUG ACTIVITY; DRUG APPROVAL; EPSTEIN BARR VIRUS; FOOD AND DRUG ADMINISTRATION; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; IMMUNE DEFICIENCY; INFLAMMATION; LABORATORY TEST; MALE; MYELOABLATIVE CONDITIONING; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTOSIS; PRIORITY JOURNAL; RETINITIS; REVIEW; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; VARICELLA ZOSTER VIRUS; VERRUCA VULGARIS;

ADMINISTRATION, TOPICAL; ADULT; ANTIVIRAL AGENTS; CYTOSINE; HUMANS; IMMUNOCOMPROMISED HOST; LEG; MALE; PAPILLOMAVIRIDAE; PHOSPHONIC ACIDS; SKIN; TREATMENT OUTCOME; WARTS;

EID: 29544437941     PISSN: 13982273     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2005.00099.x     Document Type: Review

References (13)

1. ZABAWSKI EJ Jr, COCKERELL CJ. Topical and intralesional cidofovir: a review of pharmacology and therapeutic effects. J Am Acad Dermatol 1998: 39: 741-745.
2. ZABAWSKI EJ Jr, SANDS B, GOETZ D, NAYLOR M, COCKERELL CJ. Treatment of verruca vulgaris with topical cidofovir. JAMA 1997: 278: 1236.
3. TOBIN AM, COTTER M, IRVINE AD, KIRBY B. Successful treatment of a refractory verruca in a child with acute lymphoblastic leukaemia with topical cidofovir. Br J Dermatol 2005: 152: 386-388.
4. DE CLERCQ E. Cidofovir in the treatment of poxvirus infections. Antiviral Res 2002: 55: 1-13.
5. CHRISTENSEN ND, PICKEL MD, BUDGEON LR, KREIDER JW. In vivo anti-papillomavirus activity of nucleoside analogues including cidofovir on CRPV-induced rabbit papillomas. Antiviral Res 2000: 48: 131-142.
6. SNOECK R, ANDREI G, DE CLERCQ E. Cidofovir in the treatment of HPV-associated lesions. Verh K Acad Geneeskd Belg 2001: 63: 93-120 (discussion 120-122).
7. COREMANS G, MARGARITIS V SNOECK R, WYNDAELE J, DE CLERCQE, GEBOES K. Topical cidofovir (HPMPC) is an effective adjuvant to surgical treatment of anogenital condylomata acuminata. Dis Colon Rectum 2003: 46: 1103-1108 (discussion 1108-1109).
8. STRAGIER I, SNOECK R, DE CLERCQ E, VAN DEN OORD JJ, VAN RANST M, DE GREEF H. Local treatment of HPV-induced skin lesions by cidofovir. J Med Virol 2002: 67: 241-245.
9. SNOECK R, BOSSENS M, PARENT D, et al. Phase II double-blind, placebo-controlled study of the safety and efficacy of cidofovir topical gel for the treatment of patients with human papillomavirus infection. Clin Infect Dis 2001: 33: 597-602.
10. DUAN J, PARIS W, DE MARTE J, ROOPCHAND D, FLEET TL, CORDINGLEY MG. Topical effects of cidofovir on cutaneous rabbit warts: treatment regimen and inoculum dependence. Antiviral Res 2000: 46: 135-144.
11. HOLDINESS MR. Contact dermatitis from topical antiviral drugs. Contact Derm 2001: 44: 265-269.
12. SHERMAN MD, FELDMAN KA, FARAHMAND SM, MARGOLIS TP. Treatment of conjunctival squamous cell carcinoma with topical cidofovir. Am J Ophthalmol 2002: 134: 432-433.
13. BIENVENU B, MARTINEZ F, DEVERGIE A, et al. Topical use of cidofovir induced acute renal failure. Transplantation 2002: 73: 661-662.